UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 28

Sortiert nach

Editorial: PTCL from genes to therapy

Frontiers in oncology, 2022-09, Vol.12, p.1014483-1014483

Janikova, Andrea

2022

Volltextzugriff (PDF)

New concepts in follicular lymphoma biology: From BCL2 to epigenetic regulators and non-coding RNAs

Seminars in oncology, 2018-10, Vol.45 (5-6), p.291-302

2018

Volltextzugriff (PDF)

Burkitt lymphoma-a retrospective analysis of data from the Registry of the Czech Lymphoma Study Group with external validation of the Burkitt lymphoma International Prognostic Index

Neoplasma, 2022-12, Vol.69 (6), p.1466

2022

Volltextzugriff (PDF)

Peripheral T-Cell Lymphomas Involving the Central Nervous System: A Report From the Czech Lymphoma Study Group Registry

Frontiers in oncology, 2022-05, Vol.12, p.874462-874462

2022

Volltextzugriff (PDF)

Frontline intensive chemotherapy improves outcome in young, high-risk patients with follicular lymphoma: pair-matched analysis from the Czech Lymphoma Study Group Database

Leukemia & lymphoma, 2017-03, Vol.58 (3), p.601-613

2017

Volltextzugriff (PDF)

Radiotherapy in early stage follicular lymphoma: is it really the gold standard?

Leukemia & lymphoma, 2015-10, Vol.56 (10), p.2999-3000

Janikova, Andrea

2015

Volltextzugriff (PDF)

Ibrutinib in mantle cell lymphoma: a real-world retrospective multi-center analysis of 77 patients treated in the Czech Republic

Annals of hematology, 2023-01, Vol.102 (1), p.107-115

2023

Volltextzugriff (PDF)

ATM and TP53 mutations show mutual exclusivity but distinct clinical impact in mantle cell lymphoma patients

Leukemia & lymphoma, 2019-05, Vol.60 (6), p.1420-1428

2019

Volltextzugriff (PDF)

STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma

Leukemia, 2021-05, Vol.35 (5), p.1500-1505

2021

Volltextzugriff (PDF)

Comparison of Subcutaneous Versus Intravenous Administration of Rituximab As Maintenance Treatment for Follicular Lymphoma: Results From a Two-Stage, Phase IB Study

Journal of clinical oncology, 2014-06, Vol.32 (17), p.1782-1791

2014

Volltextzugriff (PDF)

Resminostat in patients with relapsed or refractory Hodgkin lymphoma: results of the phase II SAPHIRE study

Leukemia & lymphoma, 2019-02, Vol.60 (3), p.675-684

2019

Volltextzugriff (PDF)

First-line therapy for T cell lymphomas: a retrospective population-based analysis of 906 T cell lymphoma patients

Annals of hematology, 2019-08, Vol.98 (8), p.1961-1972

2019

Volltextzugriff (PDF)

Analysis of data collected in the European Society for Blood and Marrow Transplantation (EBMT) Registry on a cohort of lymphoma patients receiving plerixafor

Bone marrow transplantation (Basingstoke), 2020-03, Vol.55 (3), p.613-622

2020

Volltextzugriff (PDF)

Role of rituximab in treatment of patients with primary central nervous system lymphoma: a retrospective analysis of the Czech lymphoma study group registry

Leukemia & lymphoma, 2016-12, Vol.57 (12), p.2777-2783

2016

Volltextzugriff (PDF)

The influence of maintenance therapy of rituximab on the survival of elderly patients with follicular lymphoma. A retrospective analysis from the database of the Czech Lymphoma Study Group

Leukemia research, 2018-10, Vol.73, p.29-38

2018

Volltextzugriff (PDF)

Radiotherapy with rituximab may be better than radiotherapy alone in first-line treatment of early-stage follicular lymphoma: is it time to change the standard strategy?

Leukemia & lymphoma, 2015-08, Vol.56 (8), p.2350-2356

2015

Volltextzugriff (PDF)

The incidence of biopsy-proven transformation in follicular lymphoma in the rituximab era. A retrospective analysis from the Czech Lymphoma Study Group (CLSG) database

Annals of hematology, 2018-04, Vol.97 (4), p.669-678

2018

Volltextzugriff (PDF)

Maintenance rituximab in newly diagnosed mantle cell lymphoma patients: a real world analysis from the Czech lymphoma study group registry

Leukemia & lymphoma, 2019-02, Vol.60 (3), p.748-755

2019

Volltextzugriff (PDF)

Potential loss of prognostic significance of minimal residual disease assessment after R‐CHOP‐based induction in elderly patients with mantle cell lymphoma in the era of rituximab maintenance

Hematological oncology, 2018-12, Vol.36 (5), p.773-778

2018

Volltextzugriff (PDF)

The interval between progression and therapy initiation is the key prognostic parameter in relapsing diffuse large B cell lymphoma: analysis from the Czech Lymphoma Study Group database (NIHIL)

Annals of hematology, 2020-07, Vol.99 (7), p.1583-1594

2020

Volltextzugriff (PDF)

Alternating R‐CHOP and R‐cytarabine is a safe and effective regimen for transplant‐ineligible patients with a newly diagnosed mantle cell lymphoma

Hematological oncology, 2018-02, Vol.36 (1), p.110-115

2018

Volltextzugriff (PDF)

Retrospective analysis of 235 unselected patients with mantle cell lymphoma confirms prognostic relevance of Mantle Cell Lymphoma International Prognostic Index and Ki-67 in the era of rituximab: long-term data from the Czech Lymphoma Project Database

Leukemia & lymphoma, 2014-04, Vol.55 (4), p.802-810

2014

Volltextzugriff (PDF)

Impact of rituximab maintenance and maintenance schedule on prognosis in first-line treatment of follicular lymphoma. Retrospective analysis from Czech Lymphoma Study Group (CLSG) database

Leukemia & lymphoma, 2016-05, Vol.57 (5), p.1094-1103

2016

Volltextzugriff (PDF)

Transmission of t(11;14)-positive cells by allogeneic stem cell transplant: 10-year journey to mantle cell lymphoma

Leukemia & lymphoma, 2014-08, Vol.55 (8), p.1935-1938

2014

Volltextzugriff (PDF)

Value of [18F]Fluorodeoxyglucose Positron Emission Tomography in the Management of Follicular Lymphoma: The End of a Dilemma?

Clinical lymphoma & myeloma, 2008-10, Vol.8 (5), p.287-293

2008

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Aktive Filter

ThemaCancer

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(28)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(27)
Science & Technology
(27)
Hematology
(21)
Humans
(17)
Female
(14)
Middle Aged
(14)
Prognosis
(13)
Adult
(12)
Aged
(12)
Male
(12)
Rituximab
(10)
Treatment Outcome
(10)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(8)
Follicular Lymphoma
(8)
Lymphoma
(8)
Neoplasm Staging
(7)
Aged, 80 And Over
(6)
Lymphoma, Follicular - Pathology
(5)
Lymphoma, Mantle-Cell - Drug Therapy
(5)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Editorial: PTCL from genes to therapy

New concepts in follicular lymphoma biology: From BCL2 to epigenetic regulators and non-coding RNAs

Burkitt lymphoma-a retrospective analysis of data from the Registry of the Czech Lymphoma Study Group with external validation of the Burkitt lymphoma International Prognostic Index

Peripheral T-Cell Lymphomas Involving the Central Nervous System: A Report From the Czech Lymphoma Study Group Registry

Frontline intensive chemotherapy improves outcome in young, high-risk patients with follicular lymphoma: pair-matched analysis from the Czech Lymphoma Study Group Database

Radiotherapy in early stage follicular lymphoma: is it really the gold standard?

Ibrutinib in mantle cell lymphoma: a real-world retrospective multi-center analysis of 77 patients treated in the Czech Republic

ATM and TP53 mutations show mutual exclusivity but distinct clinical impact in mantle cell lymphoma patients

STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma

Comparison of Subcutaneous Versus Intravenous Administration of Rituximab As Maintenance Treatment for Follicular Lymphoma: Results From a Two-Stage, Phase IB Study

Resminostat in patients with relapsed or refractory Hodgkin lymphoma: results of the phase II SAPHIRE study

First-line therapy for T cell lymphomas: a retrospective population-based analysis of 906 T cell lymphoma patients

Analysis of data collected in the European Society for Blood and Marrow Transplantation (EBMT) Registry on a cohort of lymphoma patients receiving plerixafor

Role of rituximab in treatment of patients with primary central nervous system lymphoma: a retrospective analysis of the Czech lymphoma study group registry

The influence of maintenance therapy of rituximab on the survival of elderly patients with follicular lymphoma. A retrospective analysis from the database of the Czech Lymphoma Study Group

Radiotherapy with rituximab may be better than radiotherapy alone in first-line treatment of early-stage follicular lymphoma: is it time to change the standard strategy?

The incidence of biopsy-proven transformation in follicular lymphoma in the rituximab era. A retrospective analysis from the Czech Lymphoma Study Group (CLSG) database

Maintenance rituximab in newly diagnosed mantle cell lymphoma patients: a real world analysis from the Czech lymphoma study group registry

Potential loss of prognostic significance of minimal residual disease assessment after R‐CHOP‐based induction in elderly patients with mantle cell lymphoma in the era of rituximab maintenance

The interval between progression and therapy initiation is the key prognostic parameter in relapsing diffuse large B cell lymphoma: analysis from the Czech Lymphoma Study Group database (NIHIL)

Alternating R‐CHOP and R‐cytarabine is a safe and effective regimen for transplant‐ineligible patients with a newly diagnosed mantle cell lymphoma

Retrospective analysis of 235 unselected patients with mantle cell lymphoma confirms prognostic relevance of Mantle Cell Lymphoma International Prognostic Index and Ki-67 in the era of rituximab: long-term data from the Czech Lymphoma Project Database

Impact of rituximab maintenance and maintenance schedule on prognosis in first-line treatment of follicular lymphoma. Retrospective analysis from Czech Lymphoma Study Group (CLSG) database

Transmission of t(11;14)-positive cells by allogeneic stem cell transplant: 10-year journey to mantle cell lymphoma

Value of [18F]Fluorodeoxyglucose Positron Emission Tomography in the Management of Follicular Lymphoma: The End of a Dilemma?

Aktive Filter

Suchergebnisse filtern